The crosstalk between autophagy and myeloid-derived suppressor cell responses in cancer

Area of Science:

• Cancer immunology
• Cellular biology
• Autophagy research

Background:

• Myeloid-derived suppressor cells (MDSCs) accumulate in tumors, inhibiting anti-tumor immunity through cell contact and immunosuppressive factors.
• Current cancer therapies aim to modify MDSCs towards an immunogenic phenotype.
• Autophagy, a cellular degradation process, has a complex role in cancer, acting both protectively and therapeutically.

Purpose of the Study:

• To elucidate the intricate relationship between autophagy and myeloid-derived suppressor cells (MDSCs) in the context of cancer.
• To review the regulatory role of autophagy in MDSC function and its implications for anti-tumor immunity.

Main Methods:

• Literature review and synthesis of existing research on MDSCs and autophagy in cancer.
• Analysis of proposed mechanisms for MDSC-mediated immune suppression.
• Examination of indirect evidence linking autophagy to MDSC activity.

Main Results:

• MDSC accumulation is a hallmark of tumor progression, contributing to immune evasion.
• Autophagy's dual role in cancer depends on tumor stage and context.
• Emerging evidence suggests autophagy significantly influences MDSC function and immunosuppressive capacity.

Conclusions:

• Understanding the interplay between autophagy and MDSCs is crucial for developing novel cancer immunotherapies.
• Targeting autophagy may represent a viable strategy to modulate MDSC activity and enhance anti-tumor immune responses.
• Further research is warranted to fully delineate the mechanisms governing autophagy-MDSC interactions in cancer.